Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.
about
Tuberculosis Biomarkers: From Diagnosis to ProtectionCorrelates of tuberculosis risk: predictive biomarkers for progression to active tuberculosisEvidence for an elongated dimeric structure of heparin-binding hemagglutinin from Mycobacterium tuberculosisTriggered Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin folding and dimerizationHigher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral bloodIdentification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis.Pilot study of diagnostic potential of the Mycobacterium tuberculosis recombinant HBHA protein in a vaccinated population in Finland.IFN-γ and IL-2 Responses to Recombinant AlaDH against ESAT-6/CFP-10 Fusion Antigens in the Diagnosis of Latent versus Active Tuberculosis Infection.The immunology of tuberculosis: from bench to bedside.Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-respondersToward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis ImmunoproteomeTargeting of Mycobacterium tuberculosis heparin-binding hemagglutinin to mitochondria in macrophages.Differential contribution of the repeats to heparin binding of HBHA, a major adhesin of Mycobacterium tuberculosis.Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.Latent tuberculosis infection: myths, models, and molecular mechanismsImmune responses in the lungs of patients with tuberculous pleural effusion without pulmonary tuberculosis.Risk stratification of latent tuberculosis defined by combined interferon gamma release assays.Heparin-binding haemagglutinin, a new tool for the detection of latent Mycobacterium tuberculosis infection in hemodialysis patientsMycobacterial Heparin-binding Hemagglutinin Antigen Activates Inflammatory Responses through PI3-K/Akt, NF-κB, and MAPK Pathways.Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infectionContribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tubeDiagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.Heparin-binding hemagglutinin induces IFN-γ(+) IL-2(+) IL-17(+) multifunctional CD4(+) T cells during latent but not active tuberculosis disease.Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.Molecular findings and approaches spotlighting Mycobacterium bovis persistence in cattle.Diagnosing latent tuberculosis infection in the HIV era.Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in children.Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis.Tuberculosis vaccines: present and future.Biomarkers of latent TB infection.Boosting BCG to protect against TB.Tuberculosis assays: past, present and future.Update in tuberculosis and nontuberculous mycobacterial disease 2010.Redefining latent tuberculosis.Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin-antitoxin systems.Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines.Evaluation of the eukaryotic expression of mtb32C-hbha fusion gene of Mycobacterium tuberculosis in Hepatocarcinoma cell line.Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination.Altered expression of antigen-specific memory and regulatory T cell subsets differentiate latent and active Tuberculosis.Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
P2860
Q26741141-68C97242-CB76-4024-A29F-A4825D6DF233Q28077155-E761A3F9-38A7-429C-97EB-E6DBC782D8C2Q28486725-58BAF3AD-B993-4DC0-BA35-B42D463804EEQ28486977-D0B9375B-79E8-4DBD-AB78-94F5A4391A2AQ28742905-B6BDC809-5DAE-4E5E-BAE6-254296C7C350Q30945400-F341A800-7CE8-4F17-AA73-8FC83F013ED9Q33371695-00BBAC27-B544-4921-99BC-098C62644A8EQ33676945-9A310491-9F6E-498C-A05E-5CCA37CF5FD6Q33777367-1AA7A2E7-DD60-45FF-8E4E-06AFF7A29A26Q33867531-47357180-7BB0-4349-839E-971377DA3AB5Q34024201-B230AD44-40ED-47DC-8748-247D64F8B3CCQ34102768-F133B142-1F4D-4C8E-934E-8E849114ECE4Q34189467-F0A0A7D0-2B95-40E2-B20F-8812960E4B15Q34251332-5A170476-7BA3-45C4-9ACD-365191612E6AQ34297816-564021C1-E6E8-4AAF-80D0-562544A7FD4DQ34378280-51066D3B-9BD3-4D66-AF12-4F24796B532BQ34389498-49C63FA5-3144-40D3-A314-14A87BF6BFC8Q34936752-A27EB7F1-F3AF-49B7-BC9D-7E7B8E929FD4Q35000960-ECB4D8DB-E43D-4ED1-81C9-82A1CD9A0BF8Q35021144-8FDBFC62-073C-42DA-B92C-7D5CA6293919Q35110105-7F5A2B18-A493-407A-9D89-EAAA1F3BE960Q35336540-29631FE5-FE47-4780-8CC3-B0543DAAFBE5Q35940636-B6195B46-B9E5-4BC9-A50F-AC93062B239AQ37025889-C324AE7C-7C92-4FF0-953E-E75178A8AB60Q37394401-A0974AD0-1F5D-4062-BC03-52C6A55B226BQ37431509-BF4191B6-98D9-494C-820D-3108EF5C6710Q37545069-DEDF674E-421D-48DD-822C-9896212AFF29Q37643318-3629556B-3B04-4F3E-91E3-81BF5DB0A0E2Q37754908-BC737DB9-1460-4120-A11D-C6D5AE11CF14Q37755029-BB2CB96B-1A17-4DC8-9C85-2D21264AE627Q37762830-677549D4-39E9-4ACA-BABA-18714A8918E4Q37866817-267647F8-5A64-4942-A018-B9C1B5739EB0Q37902000-CEB20422-85D2-47B9-8A13-D513883865F4Q37940571-CFC11388-FB91-4FD4-A4E9-C1F5601B9CF7Q38492505-97A9A624-3AAA-4BA7-A7DC-5EF704AA64ACQ38620366-4FFCF584-4430-47C4-BF3F-81C0D02D17BAQ38764202-5C9E660B-B86B-4191-BDA9-6EA37A6A52CDQ39473407-31BEA5A3-5347-4028-9F18-70399286E1A3Q40062509-0D9478D7-0D86-4713-8DA9-A53AA10BF6D4Q40233467-5416FFED-6F8E-461A-A211-13C45610DA08
P2860
Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Heparin-binding-hemagglutinin- ...... tool for latent tuberculosis.
@ast
Heparin-binding-hemagglutinin- ...... tool for latent tuberculosis.
@en
Heparin-binding-hemagglutinin- ...... tool for latent tuberculosis.
@nl
type
label
Heparin-binding-hemagglutinin- ...... tool for latent tuberculosis.
@ast
Heparin-binding-hemagglutinin- ...... tool for latent tuberculosis.
@en
Heparin-binding-hemagglutinin- ...... tool for latent tuberculosis.
@nl
prefLabel
Heparin-binding-hemagglutinin- ...... tool for latent tuberculosis.
@ast
Heparin-binding-hemagglutinin- ...... tool for latent tuberculosis.
@en
Heparin-binding-hemagglutinin- ...... tool for latent tuberculosis.
@nl
P2093
P2860
P50
P1433
P1476
Heparin-binding-hemagglutinin- ...... tool for latent tuberculosis.
@en
P2093
Annie Drowart
Françoise Mascart
Jean-Paul Van Vooren
Kinda Schepers
Sammy Place
T Mark Doherty
Virginie Verscheure
Véronique Lechevin
P2860
P356
10.1371/JOURNAL.PONE.0000926
P407
P577
2007-10-03T00:00:00Z